Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Boccia

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|July 19, 2012
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survivalEric Sanchez, Mingjie Li, Alex Kitto, et al.
British Journal of Haematology|October 6, 2021
Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab studyDarla K Liles, Nirmish R Shah, Brigid Scullin, et al.
Cancer|January 18, 2017
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromesGuillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G Berdeja, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2026
Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6David Andorsky, Adelba Torres Lopez, Rakhee Vaidya, et al.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
American Journal of Clinical Pathology|June 12, 2020
Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal CancerGregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
British Journal of Haematology|July 19, 2012
Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survivalEric Sanchez, Mingjie Li, Alex Kitto, et al.
British Journal of Haematology|October 6, 2021
Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab studyDarla K Liles, Nirmish R Shah, Brigid Scullin, et al.
Cancer|January 18, 2017
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromesGuillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G Berdeja, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2026
Epcoritamab Monotherapy as Outpatient Treatment for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Interim Results From EPCORE NHL-6David Andorsky, Adelba Torres Lopez, Rakhee Vaidya, et al.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
Nature Biomedical Engineering|November 29, 2025
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cuesC Andrew Stewart, Shaji Daniel, Elizabeth J Curvino, et al.
American Journal of Clinical Pathology|June 12, 2020
Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal CancerGregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, et al.
Pageof 5